Anxiety and depression levels in psoriatic patients in Almaty, Kazakhstan

Ramzia Kakar, Said Abdul Ghafour Saeedy, A. Haidery, Dinara Rysbekova, У.Т. Бейсебаева

2024

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.5114/dr.2024.146622
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

IntroductIonPsoriasis is a chronic, immune-mediated disorder resulting from a polygenic predisposition and environmental triggers such as trauma, infections, medi-cations, and psychological stress [1].Mental health comorbidities are more significant in psoriatic patients than those without psoriasis or other skin diseases [2].Studies show that 10% to 62% of psoriatic patients are diagnosed with depression [3].Many pa-AbstrAct Introduction: Psoriasis is the most common skin disease in Kazakhstan.Psoriatic patients are at increased risk of anxiety and depression.The psychological stress that triggers psoriasis can affect the treatment response.Objective: To determine the prevalence of depression and anxiety in psoriatic patients in Almaty.Material and methods: This prospective cross-sectional study was conducted at Kazakh's Scientific Center of Dermatology and Infectious Disease and Almaty Venereology Dispenser from November 2020 to April 2021.We used the PASI scale to assess psoriasis severity and the HADS and Hamilton scales for identification and assessment of depression and anxiety.Results: The prevalence of anxiety and depression was 47.4% and 46.5%, respectively.Both anxiety and depression were registered in 39.7% of men and 61.0% and 58.5% of women, respectively.Most patients had moderate pruritus.The pruritus severity was associated with anxiety (p = 0.014) and depression (p = 0.025).Patients with a low level of education were more prone to severe depression (p = 0.002).The types of psoriasis in our patients included psoriasis vulgaris (74.0%), guttate (9.3%), erythrodermic (7.4%), pustular (5.6%), and palmoplantar (3.7%) forms.No statistically significant difference in the prevalence of anxiety (p = 0.623) and depression (p = 0.565) was revealed among patients with different clinical forms of psoriasis.Conclusions: Anxiety and depression are common among psoriatic patients, especially in females.The disease severity correlates with the severity of anxiety but not with depression.Comorbidities increase the likelihood of depression.Further studies with control groups or population-based studies are required to determine the impact of psoriasis on mental health.